IDT Biologika

Germany
Biologics Cell & Gene Therapy Sterile Fill-Finish
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ✓ Press (4) ✓ EMA GMP (2) ○ MHRA GMP ✓ HC GMP (7)

Quick Facts: IDT Biologika

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Germany
Website
Modalities
Biologics, Cell & Gene Therapy, Sterile Fill-Finish
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About IDT Biologika

IDT Biologika is a contract development and manufacturing organization (CDMO). Capabilities: Biologics, Cell & Gene Therapy, Sterile Fill-Finish. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://idt-biologika.de/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

IDT Biologika FDA Inspection History

2023-09
2023-08
NAI VAI OAI
Date Site Type Observations Classification
2023-09-08
IDT Biologika GmbH
Dessau-Rosslau Company-level
Vaccines and Allergenic Products Yes Voluntary Action Indicated (VAI)
2023-08-25
IDT Biologika GmbH
Dessau-Rosslau Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

IDT Biologika FDA 483 Findings 5 observations · 2023-09-08 → 2023-09-08 ?

By subsystem

  • Personnel & Training 1 (20.0%)
  • Other 1 (20.0%)
  • Laboratory Controls 1 (20.0%)
  • Environmental Monitoring 1 (20.0%)
  • Data Integrity 1 (20.0%)

By severity

  • 5 — Critical: 1
  • 4 — Serious: 1
  • 3 — Moderate: 1
  • 2 — Minor: 2
  • Repeat observations: 0

Most severe findings

  • Critical (5) Data Integrity 2023-09-08 21 CFR 211.68(b)
    Backup data not assured as exact and complete

    "Backup data is not assured as exact, complete and secure from alteration, erasure or loss through keeping hard copy or alternate systems."

  • Serious (4) Environmental Monitoring 2023-09-08 21 CFR 211.42(c)(10)(iv)
    Environmental Monitoring System

    "Aseptic processing areas are deficient regarding the system for monitoring environmental conditions."

  • Moderate (3) Laboratory Controls 2023-09-08 21 CFR 211.194(a)(2)
    Suitability of testing methods verified

    "The suitability of all testing methods is not verified under actual conditions of use."

IDT Biologika EMA GMP Compliance 2 certificates

2024-09
2024-09
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DE_ST_01_GMP_2025_0004 IDT Biologika GmbH Germany 2024-09-04 COMPLIANT
DE_ST_01_GMP_2025_0005 IDT Biologika GmbH Germany 2024-09-04 COMPLIANT
Source: EMA EudraGMDP · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 4 articles

Company announcements, not verified evidence. They do not change any score.
news Wed, 05 No
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025 - PR Newswire
news Tue, 27 Fe
Takeda taps Biological E to ⁠ramp up Qdenga manufacturing capacity on quest to make 100M doses a year - Fierce Pharma
news Tue, 21 Oc
From the experts: How to successfully implement Annex 1 regulations - Pharmaceutical Technology
news Thu, 27 Ju
SK Bioscience begins 'globalization' push, paying $244M for majority stake in contract manufacturer IDT Biologika - Fierce Pharma

Frequently Asked Questions About IDT Biologika

How many FDA inspections does IDT Biologika have on record?
CDMO Signal tracks 2 FDA inspections for IDT Biologika, sourced from the FDA inspection database. See the full inspection history above.
Has IDT Biologika received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for IDT Biologika.
Does IDT Biologika hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 EMA GMP certificates for IDT Biologika.
Does IDT Biologika have a CDMO Signal Score?
Not yet. IDT Biologika is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating IDT Biologika for a manufacturing program?
Use the free AI matchmaker to compare IDT Biologika against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → Cell & Gene Therapy CDMOs →

Similar CDMOs

GBI (Goodwin Biotechnology)
Plantation, Florida, USA
Biologics, ADC / Bioconjugation, Sterile Fill-Finish
Prothya Biosolutions
Amsterdam, Netherlands; Brussels, Belgium
Biologics, Sterile Fill-Finish
Shilpa Medicare
India (registered sites)
Small Molecule API, Oral Solid Dose, Sterile Fill-Finish, Biologics, Peptides & Oligos
Kedrion Biopharma
Italy (Barga / Bolognana, Lucca); USA (Melville, NY)
Biologics, Sterile Fill-Finish
BE Biosol
India
Biologics, Sterile Fill-Finish

Compare IDT Biologika with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on IDT Biologika
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.